Lavinia Alberi
Research Subjects
Lavinia Alberi has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
Emanuele Brai
BrainFit4Life , Fribourg
10 shared publications- Swananda Marathe
Centre for Neuroscience, Indian Institute of Science
8 shared publications Eleonora Terrabuio
Department of Medicine, Section of General Pathology, University of Verona, Verona, Italy
5 shared publicationsIsabel Dupanloup
Swiss Institute for Bioinformatics, Lausanne, Switzerland
5 shared publicationsMarie-Agnes Doucey
University of Lausanne, Lausanne, Switzerland
5 shared publicationsPraveen Bathini
Department of Medicine, University of Fribourg, Fribourg, Switzerland
5 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14, e93304
Safety and Performance Evaluation of a Clinical Decision Support System for Imatinib Therapeutic Drug Monitoring: In Silico Study
Background: Therapeutic drug monitoring (TDM) aims to optimize clinical outcomes but is hindered by logistical delays and susceptibility to data errors. Integrating model-informed precision dosing with point-of-care testing, fortified by rule-based validation and alerts, forms a transformative clinical decision support system (CDSS) essential for securing this complex workflow. Objective: This study evaluates, in silico , the effectiveness of a rule-based CDSS for imatinib in detecting data-quality issues and optimizing therapeutic dosing, compared with a human TDM expert. Methods: We simulated a set of 60 virtual patients using a previously developed population pharmacokinetic model and deliberately enriched it with data-quality errors (eg, timing inaccuracies and reporting errors) to stress-test system resilience. We compared CDSS and TDM expert performances based on their error-detection capabilities and the clinical impact on therapeutic target attainment and safety. Results: The CDSS and the expert demonstrated comparable error-detection capabilities. The CDSS showed numerically higher sensitivity (53%, 95% CI 35%‐70% vs 45%, 95% CI 30%‐61%) and lower specificity (83%, 95% CI 63%‐95% vs 100%, 95% CI 81%‐100%). Clinically, the CDSS demonstrated significantly higher rates of target attainment than the expert (33/60, 55% vs 22/60, 37%; P =.046). However, the CDSS resulted in 5 detrimental outcomes against 1 for the TDM expert, in which patients initially within the target range fell outside it. Conclusions: The CDSS demonstrated high efficacy in optimizing imatinib exposure while serving as a robust digital gatekeeper. While active optimization drives higher efficacy, a few observed detrimental cases highlight that algorithmic safety remains contingent on data integrity. This proof-of-concept study validates the CDSS architecture as a prerequisite for future prospective clinical trials.
- 21 October 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14, e93304
Open AccessSafety and Performance Evaluation of a Clinical Decision Support System for Imatinib Therapeutic Drug Monitoring: In Silico Study
Background: Therapeutic drug monitoring (TDM) aims to optimize clinical outcomes but is hindered by logistical delays and susceptibility to data errors. Integrating model-informed precision dosing with point-of-care testing, fortified by rule-based validation and alerts, forms a transformative clinical decision support system (CDSS) essential for securing this complex workflow. Objective: This study evaluates, in silico , the effectiveness of a rule-based CDSS for imatinib in detecting data-quality issues and optimizing therapeutic dosing, compared with a human TDM expert. Methods: We simulated a set of 60 virtual patients using a previously developed population pharmacokinetic model and deliberately enriched it with data-quality errors (eg, timing inaccuracies and reporting errors) to stress-test system resilience. We compared CDSS and TDM expert performances based on their error-detection capabilities and the clinical impact on therapeutic target attainment and safety. Results: The CDSS and the expert demonstrated comparable error-detection capabilities. The CDSS showed numerically higher sensitivity (53%, 95% CI 35%‐70% vs 45%, 95% CI 30%‐61%) and lower specificity (83%, 95% CI 63%‐95% vs 100%, 95% CI 81%‐100%). Clinically, the CDSS demonstrated significantly higher rates of target attainment than the expert (33/60, 55% vs 22/60, 37%; P =.046). However, the CDSS resulted in 5 detrimental outcomes against 1 for the TDM expert, in which patients initially within the target range fell outside it. Conclusions: The CDSS demonstrated high efficacy in optimizing imatinib exposure while serving as a robust digital gatekeeper. While active optimization drives higher efficacy, a few observed detrimental cases highlight that algorithmic safety remains contingent on data integrity. This proof-of-concept study validates the CDSS architecture as a prerequisite for future prospective clinical trials.
- Open Access
- 28 September 2026
- Published by Springer Nature in Research Square
Multidimensional Monitoring of Recovery States, Biomarkers, Workload, and Performance in Elite Basketball: An Exploratory Longitudinal Field Study
Purpose Elite team-sport programs increasingly combine athlete-reported wellness ratings with biochemical markers, yet the applied interpretation of these multimodal data remains uncertain. This exploratory longitudinal field study examined whether recovery-related athlete-reported states were associated with salivary markers, acute competition exposure, and performance-readiness profiles in elite basketball players. Methods The dataset comprised 309 observations from 13 elite basketball players monitored over 15 weeks. Athlete-reported variables included calmness, stress, anger, sleep quality, tiredness, muscle soreness, energy, and sleep duration. Salivary biomarkers included pH, uric acid, aspartate aminotransferase (AST), creatine kinase (CK), ketones, and immunoglobulin A (IgA). Minutes played were used as an indicator of acute competition exposure. Analyses included correlations and biomarker stratification, exploratory risk-enrichment analyses for biomarker abnormalities, fast-versus-slow subjective recovery comparisons, mixed-effects models of post-game-to-recovery change scores, and performance-readiness group comparisons. Results Severe muscle soreness and low energy were the clearest subjective flags of biomarker abnormality. The strongest enrichment was observed for low IgA among severe-soreness observations, with a rate of 75.0% compared with 14.9% among trait-negative observations. Salivary pH differentiated fast and slow recovery from tiredness (p = 0.0167), whereas AST differentiated recovery phenotypes for energy (p = 0.0130), calmness (p = 0.0240), and anger (p = 0.0385). In mixed-effects models adjusted for minutes played, tiredness change was negatively associated with salivary pH, while anger change remained positively associated with ketones and CK. Selected associations involving tiredness and calmness also varied according to minutes played. Good- and poor-performance-readiness observations showed significantly different multivariate profiles (Wilks lambda = 0.3564, F = 25.02, p < 0.001); good-performance-readiness observations were characterized by greater calmness, better sleep quality, higher energy, lower stress and soreness, and lower IgA concentrations. Conclusions Selected athlete-reported recovery and affective states were associated with distinct, although heterogeneous, salivary biomarker and performance-readiness profiles. Integrating athlete-reported measures with biomarkers and recent competition exposure may support more informed recovery and readiness decisions in elite basketball, particularly when changes are interpreted longitudinally and relative to individual athlete baselines.
- 28 September 2026
- Published by Springer Nature in Research Square
Open AccessMultidimensional Monitoring of Recovery States, Biomarkers, Workload, and Performance in Elite Basketball: An Exploratory Longitudinal Field Study
Purpose Elite team-sport programs increasingly combine athlete-reported wellness ratings with biochemical markers, yet the applied interpretation of these multimodal data remains uncertain. This exploratory longitudinal field study examined whether recovery-related athlete-reported states were associated with salivary markers, acute competition exposure, and performance-readiness profiles in elite basketball players. Methods The dataset comprised 309 observations from 13 elite basketball players monitored over 15 weeks. Athlete-reported variables included calmness, stress, anger, sleep quality, tiredness, muscle soreness, energy, and sleep duration. Salivary biomarkers included pH, uric acid, aspartate aminotransferase (AST), creatine kinase (CK), ketones, and immunoglobulin A (IgA). Minutes played were used as an indicator of acute competition exposure. Analyses included correlations and biomarker stratification, exploratory risk-enrichment analyses for biomarker abnormalities, fast-versus-slow subjective recovery comparisons, mixed-effects models of post-game-to-recovery change scores, and performance-readiness group comparisons. Results Severe muscle soreness and low energy were the clearest subjective flags of biomarker abnormality. The strongest enrichment was observed for low IgA among severe-soreness observations, with a rate of 75.0% compared with 14.9% among trait-negative observations. Salivary pH differentiated fast and slow recovery from tiredness (p = 0.0167), whereas AST differentiated recovery phenotypes for energy (p = 0.0130), calmness (p = 0.0240), and anger (p = 0.0385). In mixed-effects models adjusted for minutes played, tiredness change was negatively associated with salivary pH, while anger change remained positively associated with ketones and CK. Selected associations involving tiredness and calmness also varied according to minutes played. Good- and poor-performance-readiness observations showed significantly different multivariate profiles (Wilks lambda = 0.3564, F = 25.02, p < 0.001); good-performance-readiness observations were characterized by greater calmness, better sleep quality, higher energy, lower stress and soreness, and lower IgA concentrations. Conclusions Selected athlete-reported recovery and affective states were associated with distinct, although heterogeneous, salivary biomarker and performance-readiness profiles. Integrating athlete-reported measures with biomarkers and recent competition exposure may support more informed recovery and readiness decisions in elite basketball, particularly when changes are interpreted longitudinally and relative to individual athlete baselines.
- Open Access
Salivary Dysbiosis Aligns with an Olfactory–Cognitive Phenotype in Aging
Background: Scalable, non–invasive markers for cognitive decline risk are limited. Olfactory dysfunction is predictive, and oral dysbiosis is mechanistically linked to neurocognitive pathways. Hence, we tested whether pairing smell and global cognition with salivary microbiome profiling yields a targeted, clinically useful signal. Methods: We enrolled 113 Memory Center attendees and community controls. Same day MMSE, UPSIT, and saliva were obtained for 16S rRNA gene sequencing and cytokine measurement. Unsupervised k means clustering on standardized MMSE–UPSIT defined two groups of participants: CNN (cognitively normal, normosmia) and CIH (cognitively impaired, hyposmia). Ordination and elastic–net models adjusted for age, sex, BMI, and sequencing depth. Functions were inferred with PICRUSt2 and were integrated with taxa via DIABLO. Results: Overall, the 16S–based microbial community structure was similar between groups, indicating minor compositional shifts. CIH showed enrichment of periodontal anaerobes (Porphyromonas, Treponema and Prevotella), whereas CNN retained nitrate reducing commensals (e.g. Neisseria subflava, Aggregatibacter aphrophilus). Functional shifts showed mixed consistency with literature, aligning for outer membrane usher proteins and alkyldihydroxy phosphate synthase, but diverging for thiaminase, alphaglucuronidase, and chemotaxis protein CheX. Most salivary cytokines levels did not differ between groups. Conclusions: This integrated smell, cognition, and saliva workflow delineates an olfactory cognitive phenotype linked to a targeted, potentially modifiable salivary dysbiosis, periodontal anaerobes vs nitrate–reducers, rather than diffuse salivary inflammatory elevation. This approach may support non–invasive triage and monitoring along the oral–brain axis, pending independent, longitudinal validation.
Open AccessSalivary Dysbiosis Aligns with an Olfactory–Cognitive Phenotype in Aging
Background: Scalable, non–invasive markers for cognitive decline risk are limited. Olfactory dysfunction is predictive, and oral dysbiosis is mechanistically linked to neurocognitive pathways. Hence, we tested whether pairing smell and global cognition with salivary microbiome profiling yields a targeted, clinically useful signal. Methods: We enrolled 113 Memory Center attendees and community controls. Same day MMSE, UPSIT, and saliva were obtained for 16S rRNA gene sequencing and cytokine measurement. Unsupervised k means clustering on standardized MMSE–UPSIT defined two groups of participants: CNN (cognitively normal, normosmia) and CIH (cognitively impaired, hyposmia). Ordination and elastic–net models adjusted for age, sex, BMI, and sequencing depth. Functions were inferred with PICRUSt2 and were integrated with taxa via DIABLO. Results: Overall, the 16S–based microbial community structure was similar between groups, indicating minor compositional shifts. CIH showed enrichment of periodontal anaerobes (Porphyromonas, Treponema and Prevotella), whereas CNN retained nitrate reducing commensals (e.g. Neisseria subflava, Aggregatibacter aphrophilus). Functional shifts showed mixed consistency with literature, aligning for outer membrane usher proteins and alkyldihydroxy phosphate synthase, but diverging for thiaminase, alphaglucuronidase, and chemotaxis protein CheX. Most salivary cytokines levels did not differ between groups. Conclusions: This integrated smell, cognition, and saliva workflow delineates an olfactory cognitive phenotype linked to a targeted, potentially modifiable salivary dysbiosis, periodontal anaerobes vs nitrate–reducers, rather than diffuse salivary inflammatory elevation. This approach may support non–invasive triage and monitoring along the oral–brain axis, pending independent, longitudinal validation.
- Open Access
- 10 February 2026
- Published by Springer Nature in Research Square
A Case Study using Physiological and Wellness Indicators for Performance Optimization in Basketball
Purpose This study investigated relationships between recovery-related biomarkers and game performance in professional basketball players to identify actionable indicators for optimizing athletic performance. Methods Thirteen professional male basketball players were monitored longitudinally over 15 weeks during games at 3-4 day intervals. Twelve independent variables—four salivary biomarkers (testosterone, cortisol, testosterone-to-cortisol ratio, salivary nitrates) and eight self-reported measures (anger, calmness, stress, energy, muscle soreness, tiredness, sleep duration, sleep quality)—were examined against 26 game performance metrics. Stratification analysis on four key outcomes (Plus/Minus, Efficiency, Player Impact Rating per minute, minutes played) identified non-linear relationships and predictor importance. Results Among the 69 significant correlations among recovery variables and game performance metrics, Tiredness and muscle soreness showed the strongest positive relationships, accounting for 39.1% of significant correlations. Sleep duration was the most consistent negative predictor (13 inverse correlations). Stratification revealed 20 significant associations with predominantly non-linear patterns. Sleep duration best predicted minutes played (H=18.47, p=0.0001, ε²=0.131); muscle soreness best predicted PIR/min (H=10.97, p=0.0042, ε²=0.081). Psychological variables primarily influenced playing time and Plus/Minus. Salivary biomarkers showed small but significant effects. Subjective recovery metrics demonstrated superior predictive value (43.8%) versus biomarkers (18.8%). Conclusions Recovery-performance relationships in elite basketball are complex, non-linear, and context-dependent. Subjective markers provide more informative readiness assessment than isolated biomarkers. Inverse sleep duration-performance associations suggest compensatory mechanisms, emphasizing individualized interpretation. Practical monitoring should prioritize daily self-reports, player-specific reference ranges, and integrate recovery data with training load contextual factors.
- 10 February 2026
- Published by Springer Nature in Research Square
Open AccessA Case Study using Physiological and Wellness Indicators for Performance Optimization in Basketball
Purpose This study investigated relationships between recovery-related biomarkers and game performance in professional basketball players to identify actionable indicators for optimizing athletic performance. Methods Thirteen professional male basketball players were monitored longitudinally over 15 weeks during games at 3-4 day intervals. Twelve independent variables—four salivary biomarkers (testosterone, cortisol, testosterone-to-cortisol ratio, salivary nitrates) and eight self-reported measures (anger, calmness, stress, energy, muscle soreness, tiredness, sleep duration, sleep quality)—were examined against 26 game performance metrics. Stratification analysis on four key outcomes (Plus/Minus, Efficiency, Player Impact Rating per minute, minutes played) identified non-linear relationships and predictor importance. Results Among the 69 significant correlations among recovery variables and game performance metrics, Tiredness and muscle soreness showed the strongest positive relationships, accounting for 39.1% of significant correlations. Sleep duration was the most consistent negative predictor (13 inverse correlations). Stratification revealed 20 significant associations with predominantly non-linear patterns. Sleep duration best predicted minutes played (H=18.47, p=0.0001, ε²=0.131); muscle soreness best predicted PIR/min (H=10.97, p=0.0042, ε²=0.081). Psychological variables primarily influenced playing time and Plus/Minus. Salivary biomarkers showed small but significant effects. Subjective recovery metrics demonstrated superior predictive value (43.8%) versus biomarkers (18.8%). Conclusions Recovery-performance relationships in elite basketball are complex, non-linear, and context-dependent. Subjective markers provide more informative readiness assessment than isolated biomarkers. Inverse sleep duration-performance associations suggest compensatory mechanisms, emphasizing individualized interpretation. Practical monitoring should prioritize daily self-reports, player-specific reference ranges, and integrate recovery data with training load contextual factors.
- Open Access
- 10 September 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (Supplement) , S150-S164
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease
Sensory functions of organs of the head and neck allow humans to interact with the environment and establish social bonds. With aging, smell, taste, vision, and hearing decline. Evidence suggests that accelerated impairment in sensory abilities can reflect a shift from healthy to pathological aging, including the development of Alzheimer's disease (AD) and other neurological disorders. While the drivers of early sensory alteration in AD are not elucidated, insults such as trauma and infections can affect sensory function. Herein, we review the involvement of the major head and neck sensory systems in AD, with emphasis on microbes exploiting sensory pathways to enter the brain (the “gateway” hypothesis) and the potential feedback loop by which sensory function may be impacted by central nervous system infection. We emphasize detection of sensory changes as first-line surveillance in senior adults to identify and remove potential insults, like microbial infections, that could precipitate brain pathology.
- 10 September 2024
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (Supplement) , S150-S164
Open AccessSensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease
Sensory functions of organs of the head and neck allow humans to interact with the environment and establish social bonds. With aging, smell, taste, vision, and hearing decline. Evidence suggests that accelerated impairment in sensory abilities can reflect a shift from healthy to pathological aging, including the development of Alzheimer's disease (AD) and other neurological disorders. While the drivers of early sensory alteration in AD are not elucidated, insults such as trauma and infections can affect sensory function. Herein, we review the involvement of the major head and neck sensory systems in AD, with emphasis on microbes exploiting sensory pathways to enter the brain (the “gateway” hypothesis) and the potential feedback loop by which sensory function may be impacted by central nervous system infection. We emphasize detection of sensory changes as first-line surveillance in senior adults to identify and remove potential insults, like microbial infections, that could precipitate brain pathology.
- Open Access
Dysosmia and dysgeusia as differential diagnostics for clinical triaging of COVID-19 cases
Smell and taste disorders are recognized as frequent, and often the only, signs occurring in the early phase of SARS-Cov-2 infection and in many cases perdure as post-viral symptoms. This evidence raised a general reconsideration of chemosensory deficits, further suggesting that their appearance can be considered as a discriminative and predictive tool to detect COVID-19 cases. In this study, encompassing the first and second pandemic wave, participants estimated their olfactory and gustatory sensitivity, plus they were administered the validated Brief Smell Identification Test (BSIT). We observed that smell and taste impairments were mainly experienced by COVID-19-positive subjects with comparable severity of respiratory symptoms as non-COVID-19 patients. In addition, we noticed that the diagnostic power of subjective olfactory assessments upon SARS-Cov-2 infection is comparable to quantitative evaluation, suggesting that self-reporting could be adopted as the first line of intervention, anticipating more exhaustive procedures aimed at containing COVID-19 diffusion and consequently preserving general health. Overall, results from this work share similarity with other studies, therefore further underlying that olfactory and gustatory disbalance can be distinctive hallmarks in COVID-19 continuum.
Open AccessDysosmia and dysgeusia as differential diagnostics for clinical triaging of COVID-19 cases
Smell and taste disorders are recognized as frequent, and often the only, signs occurring in the early phase of SARS-Cov-2 infection and in many cases perdure as post-viral symptoms. This evidence raised a general reconsideration of chemosensory deficits, further suggesting that their appearance can be considered as a discriminative and predictive tool to detect COVID-19 cases. In this study, encompassing the first and second pandemic wave, participants estimated their olfactory and gustatory sensitivity, plus they were administered the validated Brief Smell Identification Test (BSIT). We observed that smell and taste impairments were mainly experienced by COVID-19-positive subjects with comparable severity of respiratory symptoms as non-COVID-19 patients. In addition, we noticed that the diagnostic power of subjective olfactory assessments upon SARS-Cov-2 infection is comparable to quantitative evaluation, suggesting that self-reporting could be adopted as the first line of intervention, anticipating more exhaustive procedures aimed at containing COVID-19 diffusion and consequently preserving general health. Overall, results from this work share similarity with other studies, therefore further underlying that olfactory and gustatory disbalance can be distinctive hallmarks in COVID-19 continuum.
- Open Access
- 21 December 2022
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 28, 100568
Systemic Inflammation Causes Microglial Dysfunction With a Vascular AD phenotype
- 21 December 2022
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 28, 100568
Open AccessSystemic Inflammation Causes Microglial Dysfunction With a Vascular AD phenotype
- Open Access
- 2 June 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (9) , 4277-4286
COVID salivary diagnostics: A comparative technical study
Since the beginning of the coronavirus disease 2019 (COVID‐19) pandemic, molecular diagnostics of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) have taken center stage in the detection of infected individuals for isolation purposes but also in the mass surveillance as a preventive strategy to contain the virus spread. While nasopharyngeal swabs (NPS) have remained the golden standard substrate, salivary diagnostic for SARS‐CoV‐2 has been proposed as an alternative and noninvasive measure in vulnerable individuals. Nevertheless, there is a widespread assumption that salivary reverse‐transcription polymerase chain reaction (RT‐PCR) does not match the quality of testing using NPS and particular care should be taken in respect to food or beverage intake, when sampling saliva. Our study indicates that without any precaution in the selection of 190 patients, nor restriction over the time window of sampling, there is 99% match in the COVID‐19 positivity between NPS and saliva when using RT‐PCR, with a reported Delta in thermal cycles (Cts) values for the viral genes Envelope (E) and Open reading frame 1ab (Orf1ab) between 0 and 2, a 98.7% sensitivity and 100% specificity. This high accuracy is maintained in pooling configurations that can be used for mass‐testing purposes in professional and educational settings. The further advantage to using crude saliva as compared to NPS or mouthwash is that direct methods yield robust results. Overall, our study validates and promotes the use of salivary diagnostic for COVID‐19 eliminating the need of a medical practitioner for the sampling, resolving the unpleasantness of the NPS intervention and empowering the patient to do self‐testing in times of need.
- 2 June 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (9) , 4277-4286
Open AccessCOVID salivary diagnostics: A comparative technical study
Since the beginning of the coronavirus disease 2019 (COVID‐19) pandemic, molecular diagnostics of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) have taken center stage in the detection of infected individuals for isolation purposes but also in the mass surveillance as a preventive strategy to contain the virus spread. While nasopharyngeal swabs (NPS) have remained the golden standard substrate, salivary diagnostic for SARS‐CoV‐2 has been proposed as an alternative and noninvasive measure in vulnerable individuals. Nevertheless, there is a widespread assumption that salivary reverse‐transcription polymerase chain reaction (RT‐PCR) does not match the quality of testing using NPS and particular care should be taken in respect to food or beverage intake, when sampling saliva. Our study indicates that without any precaution in the selection of 190 patients, nor restriction over the time window of sampling, there is 99% match in the COVID‐19 positivity between NPS and saliva when using RT‐PCR, with a reported Delta in thermal cycles (Cts) values for the viral genes Envelope (E) and Open reading frame 1ab (Orf1ab) between 0 and 2, a 98.7% sensitivity and 100% specificity. This high accuracy is maintained in pooling configurations that can be used for mass‐testing purposes in professional and educational settings. The further advantage to using crude saliva as compared to NPS or mouthwash is that direct methods yield robust results. Overall, our study validates and promotes the use of salivary diagnostic for COVID‐19 eliminating the need of a medical practitioner for the sampling, resolving the unpleasantness of the NPS intervention and empowering the patient to do self‐testing in times of need.
- Open Access
Histone H3 Lysine 4 and 27 Trimethylation Landscape of Human Alzheimer’s Disease
Background: Epigenetic remodeling is emerging as a critical process for both the onset and progression of Alzheimer’s disease (AD), the most common form of neurodegenerative dementia. However, it is not clear to what extent the distribution of histone modifications is involved in AD. Methods: To investigate histone H3 modifications in AD, we compared the genome-wide distributions of H3K4me3 and H3K27me3 in entorhinal cortices from severe sporadic AD patients and from age-matched healthy individuals of both sexes. Results: AD samples were characterized by typical average levels and distributions of the H3K4me3 and H3K27me3 signals. However, AD patients showed a lower H3K4me3 and higher H3K27me3 signal, particularly in males. Interestingly, the genomic sites found differentially trimethylated at the H3K4 between healthy and AD samples involve promoter regions of genes belonging to AD-related pathways such as glutamate receptor signaling. Conclusions: The signatures of H3K4me3 and H3K27me3 identified in AD patients validate the role of epigenetic chromatin remodeling in neurodegenerative disease and shed light on the genomic adaptive mechanisms involved in AD.
Open AccessHistone H3 Lysine 4 and 27 Trimethylation Landscape of Human Alzheimer’s Disease
Background: Epigenetic remodeling is emerging as a critical process for both the onset and progression of Alzheimer’s disease (AD), the most common form of neurodegenerative dementia. However, it is not clear to what extent the distribution of histone modifications is involved in AD. Methods: To investigate histone H3 modifications in AD, we compared the genome-wide distributions of H3K4me3 and H3K27me3 in entorhinal cortices from severe sporadic AD patients and from age-matched healthy individuals of both sexes. Results: AD samples were characterized by typical average levels and distributions of the H3K4me3 and H3K27me3 signals. However, AD patients showed a lower H3K4me3 and higher H3K27me3 signal, particularly in males. Interestingly, the genomic sites found differentially trimethylated at the H3K4 between healthy and AD samples involve promoter regions of genes belonging to AD-related pathways such as glutamate receptor signaling. Conclusions: The signatures of H3K4me3 and H3K27me3 identified in AD patients validate the role of epigenetic chromatin remodeling in neurodegenerative disease and shed light on the genomic adaptive mechanisms involved in AD.
- Open Access
- 19 January 2022
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 6 (1) , 31-41
Salivary Proteomics Identifies Transthyretin as a Biomarker of Early Dementia Conversion
Background: Alzheimer’s disease (AD) remains to date an incurable disease with a long asymptomatic phase. Early diagnosis in peripheral biofluids has emerged as key for identifying subjects at risk and developing therapeutics and preventative approaches. Objective: We apply proteomics discovery to identify salivary diagnostic biomarkers for AD, which are suitable for self-sampling and longitudinal biomonitoring during aging. Methods: 57 participants were recruited for the study and were categorized into Cognitively normal (CNh) ( n = 19), mild cognitive impaired (MCI) ( n = 21), and Alzheimer’s disease (AD) ( n = 17). On a subset of subjects, 3 CNh and 3 mild AD, shot-gun filter aided sample preparation (FASP) proteomics and liquid chromatography mass spectroscopy (LC-MS/MS) was employed in saliva and cerebrospinal fluid (CSF) to identify neural-derived proteins. The protein level of salivary Transthyretin (TTR) was validated using western blot analysis across groups. Results: We found that 19.8% of the proteins in saliva are shared with CSF. When we compared the saliva and CSF proteome, 24 hits were decreased with only one protein expressed more. Among the differentially expressed proteins, TTR with reported function in amyloid misfolding, shows a significant drop in AD samples, confirmed by western blot showing a 0.5-fold reduction in MCI and AD compared to CNh. Conclusion: A reduction in salivary TTR appears with the onset of cognitive symptoms. More in general, the proteomic profiling of saliva shows a plethora of biomarkers worth pursuing as non-invasive hallmarks of dementia in the preclinical stage.
- 19 January 2022
- Published by SAGE Publications in Journal of Alzheimer's Disease Reports
- Vol. 6 (1) , 31-41
Open AccessSalivary Proteomics Identifies Transthyretin as a Biomarker of Early Dementia Conversion
Background: Alzheimer’s disease (AD) remains to date an incurable disease with a long asymptomatic phase. Early diagnosis in peripheral biofluids has emerged as key for identifying subjects at risk and developing therapeutics and preventative approaches. Objective: We apply proteomics discovery to identify salivary diagnostic biomarkers for AD, which are suitable for self-sampling and longitudinal biomonitoring during aging. Methods: 57 participants were recruited for the study and were categorized into Cognitively normal (CNh) ( n = 19), mild cognitive impaired (MCI) ( n = 21), and Alzheimer’s disease (AD) ( n = 17). On a subset of subjects, 3 CNh and 3 mild AD, shot-gun filter aided sample preparation (FASP) proteomics and liquid chromatography mass spectroscopy (LC-MS/MS) was employed in saliva and cerebrospinal fluid (CSF) to identify neural-derived proteins. The protein level of salivary Transthyretin (TTR) was validated using western blot analysis across groups. Results: We found that 19.8% of the proteins in saliva are shared with CSF. When we compared the saliva and CSF proteome, 24 hits were decreased with only one protein expressed more. Among the differentially expressed proteins, TTR with reported function in amyloid misfolding, shows a significant drop in AD samples, confirmed by western blot showing a 0.5-fold reduction in MCI and AD compared to CNh. Conclusion: A reduction in salivary TTR appears with the onset of cognitive symptoms. More in general, the proteomic profiling of saliva shows a plethora of biomarkers worth pursuing as non-invasive hallmarks of dementia in the preclinical stage.